In 2023, the sales of blood and blood derivatives for human use in the US stood at 6.825 billion USD. Based on forecasts, the projected growth from 2024 to 2028 shows a steady year-on-year increase, with sales reaching 7.6974 billion USD in 2028. The year-on-year growth rate is as follows: 2024 - 2.74%, 2025 - 2.51%, 2026 - 2.41%, 2027 - 2.30%, and 2028 - 2.21%. The compound annual growth rate (CAGR) over this period is approximately 2.4%.
Future trends to watch for include:
- Innovations in blood storage and handling technologies.
- Regulatory changes and their impact on market dynamics.
- Increasing demand for rare blood derivatives and personalized medicine.
